Difamilast: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Difamilast. Educational only — not medical advice.
Labeled uses
ADQUEY is indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis.
Source: FDA labeling via NIH DailyMed (set 46c95e41…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.